Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Humanized Mouse
76%
Human Immunodeficiency Virus
59%
Mouse
53%
Macrophage
35%
Hematopoietic Stem Cell
23%
Virus Type
19%
Human Immunodeficiency Virus Infection
15%
Microglia
15%
Mouse Model
15%
Viral Disease
13%
Adaptive Immune System
13%
Human Cell
13%
CD34
12%
Blood Brain Barrier
12%
Monocyte
12%
Blood Plasma
10%
Interleukin 34
9%
NSG Mouse
9%
Sonic Hedgehog
9%
Central Nervous System
9%
Agonist
9%
CD4
8%
Dendritic Cell
8%
Infectious Agent
7%
Brain Tissue
7%
Astrocyte
7%
T-Helper Cell
6%
CCR5
6%
Viral Load
6%
Leukocyte
6%
Secretion (Process)
6%
Bone Marrow-Derived Macrophage
6%
Single Photon Emission Computed Tomography
6%
Viral Replication
5%
Immunopathology
5%
Lymphocyte
5%
Cerebrospinal Fluid
5%
Glycoprotein
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
64%
Mouse
55%
Human Immunodeficiency Virus 1
25%
Infection
23%
Disease
20%
Atazanavir
19%
Disorders of Higher Cerebral Function
17%
Ritonavir
16%
Pharmacodynamics
15%
Nanoparticle
13%
Antivirus Agent
13%
Blood-Brain Barrier
11%
Efavirenz
11%
Folic Acid
10%
Human Immunodeficiency Virus Infection
10%
Folate Receptor
9%
Nanogel
9%
RNA Directed DNA Polymerase Inhibitor
9%
Human Immunodeficiency Virus 1 Infection
8%
Mixed Lineage Kinase 3
7%
Dolutegravir
7%
Atazanavir Plus Ritonavir
7%
HIV Associated Dementia
7%
Viral Clearance
5%
SCID Mouse
5%
Subcutaneous Injection
5%
Rilpivirine
5%
Neuroprotective Agent
5%
Cabotegravir
5%
Biodistribution
5%
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
51%
Humanized Mice
24%
Encephalitis
14%
Copolymer-1
11%
IL-34
9%
Antiretroviral Therapy
9%
NOG Mice
8%
Antiretroviral
8%
Adoptive Transfer
7%
Immune Response
7%
Efavirenz
7%
Atazanavir
7%
Virus
6%
CD34+ Stem Cells
6%
Monocyte-derived Macrophages
6%
URMC-099
5%
Macrophages
5%
Antiretroviral Activity
5%
Neuroprotective Activity
5%
Liver
5%
Mouse Model
5%
Bone Marrow
5%